Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Assets (2018 - 2025)

AVITA Medical (RCEL) has disclosed Assets for 4 consecutive years, with $56.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Assets fell 29.25% year-over-year to $56.4 million, compared with a TTM value of $56.4 million through Dec 2025, down 29.25%, and an annual FY2025 reading of $56.4 million, down 29.25% over the prior year.
  • Assets was $56.4 million for Q4 2025 at AVITA Medical, down from $63.7 million in the prior quarter.
  • Across five years, Assets topped out at $111.6 million in Q4 2023 and bottomed at $56.4 million in Q4 2025.
  • Average Assets over 4 years is $85.8 million, with a median of $87.1 million recorded in 2023.
  • The sharpest move saw Assets rose 13.61% in 2023, then tumbled 33.81% in 2025.
  • Year by year, Assets stood at $98.3 million in 2022, then increased by 13.61% to $111.6 million in 2023, then decreased by 28.6% to $79.7 million in 2024, then decreased by 29.25% to $56.4 million in 2025.
  • Business Quant data shows Assets for RCEL at $56.4 million in Q4 2025, $63.7 million in Q3 2025, and $58.1 million in Q2 2025.